About CinRx Pharma
CinRx Pharma is a company based in Cincinnati (United States) founded in 2015.. CinRx Pharma has raised $83 million across 2 funding rounds. CinRx Pharma operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Cincinnati, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$83 M (USD)
in 2 rounds
-
Latest Funding Round
$73 M (USD), Series B
May 30, 2024
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Leadership Team
7 people
Board Team
3 people
Software Development Team
1 people
Sales and Marketing
1 people
Unlock access to complete
Funding Insights of CinRx Pharma
CinRx Pharma has successfully raised a total of $83M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $73 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $73.0M
-
First Round
First Round
(30 Apr 2024)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2024 | Amount | Series B - CinRx Pharma | Valuation |
investors |
|
| Apr, 2024 | Amount | Series A - CinRx Pharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by CinRx Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CinRx Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cinrx Pharma Comparisons
Competitors of CinRx Pharma
CinRx Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cinrx Pharma
Frequently Asked Questions about CinRx Pharma
When was CinRx Pharma founded?
CinRx Pharma was founded in 2015 and raised its 1st funding round 9 years after it was founded.
Where is CinRx Pharma located?
CinRx Pharma is headquartered in Cincinnati, United States. It is registered at Cincinnati, Ohio, United States.
Who is the current CEO of CinRx Pharma?
Jonathan Isaacsohn is the current CEO of CinRx Pharma.
Is CinRx Pharma a funded company?
CinRx Pharma is a funded company, having raised a total of $83M across 2 funding rounds to date. The company's 1st funding round was a Series A of $10M, raised on Apr 30, 2024.
What does CinRx Pharma do?
CINRX Pharma is developing NMEs in multiple therapeutic areas. The company is planning to file the IND application for its lead candidate CIN-102 (Deuterated Domperidone, a dopamine 2-receptor antagonist) for the treatment of gastroparesis by the first half of 2018. Other candidates in their pipeline include CIN-103, a novel agent for IBS-D (Idiophathic Bowel Syndrome with Diarrhoea), CIN-105 for a cardiovascular indication and CIN-101, for a dermatology indication. The company has a unique partnership with Medpace, through which the CRO will offer clinical development resources through a preferred cost relationship and will also help in making early GoNo Go decisions.
Who are the top competitors of CinRx Pharma?
CinRx Pharma's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.